letrozole

The medicine is used in postmenopausal women for the treatment of advanced breast cancer (hormone receptor-positive) and in adjuvant or extended treatment in patients with early-stage hormone-dependent breast cancer.

Form: tablets, film-coated

ATC: L02BG04

Manufacturer: Celon Pharma Sp. z o.o.

The medicine is used in the hormonal treatment of breast cancer in postmenopausal women. It may be used to prevent cancer recurrence, as preoperative or postoperative treatment, or after five years of tamoxifen use, as well as to prevent the spread of the tumor.

Form: tablets, film-coated

ATC: L02BG04

Manufacturer: S.C. Sindan- Pharma S.R.L.

The medicine is used for the hormonal treatment of breast cancer in postmenopausal women. It may be used to prevent the recurrence of the disease, as preoperative or postoperative treatment (including after five years of tamoxifen use), as well as to prevent the spread of the tumor in patients with advanced breast cancer.

Form: tablets, film-coated

ATC: L02BG04

Manufacturer: Rottendorf Pharma GmbH, Synthon B.V., Synthon Hispania S.L.

The medicine is used in the hormonal treatment of breast cancer in postmenopausal women. It may be used to prevent recurrence of the disease, as preoperative treatment (when immediate surgery is not recommended), as postoperative treatment or after five years of tamoxifen use, as well as to prevent the spread of the tumor in patients with advanced breast cancer.

Form: tablets, film-coated

ATC: L02BG04

Manufacturer: Vipharm S.A.

The medicinal product is used in the treatment of breast cancer in postmenopausal women. It may be used to prevent the recurrence of the disease, as preoperative treatment (if immediate surgery is not recommended) or postoperative treatment, as well as to prevent the spread of the tumor in patients with advanced stages of the disease.

Form: tablets, film-coated

ATC: L02BG04

Manufacturer: Accord Healthcare B.V.

The medicine is used in the hormonal treatment of breast cancer in postmenopausal women. It helps to prevent the recurrence of the disease, can be used before or after surgery (including after 5 years of tamoxifen use), and also in preventing metastases in women with advanced breast cancer.

Form: tablets, film-coated

ATC: L02BG04

Manufacturer: Bluefish Pharmaceuticals AB, Genepharm S.A.

The medicine is used in the hormonal treatment of breast cancer in postmenopausal women. It helps to prevent the recurrence of the disease, can be used before or after surgery (including after five years of tamoxifen treatment), and also in preventing the spread of the tumor in patients with advanced breast cancer.

Form: tablets, film-coated

ATC: L02BG04

Manufacturer: APL Swift Services (Malta) Ltd. Arrow Generiques Generis Farmaceutica, S.A.

The medicinal product is used in the hormonal treatment of breast cancer in postmenopausal women. It helps to prevent the recurrence of the disease and may be used before surgery, after surgery, or after five years of treatment with tamoxifen, as well as in the prevention of cancer spread in patients with advanced breast cancer.

Form: tablets, film-coated

ATC: L02BG04

Manufacturer: Industria Quimica y Farmaceutica VIR S.A. Rottendorf Pharma GmbH Synthon B.V. Synthon Hispania S.L.

Lortanda is used in the treatment of breast cancer in postmenopausal women. It may be used to prevent the recurrence of the disease, as preoperative or postoperative treatment, after 5 years of tamoxifen use, and to prevent the spread of cancer in advanced stages.

Form: tablets, film-coated

ATC: L02BG04

Manufacturer: Krka, d.d., Novo mesto TAD Pharma GmbH